Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

Study Questions:

Is galectin-3, implicated in organ fibrosis, a potential therapeutic target in heart failure (HF)?